Quantcast
Home > Quotes > LH

Laboratory Corporation of America Holdings Common Stock (LH) Quote & Summary Data

LH 
$166.24
*  
1.22
0.73%
Get LH Alerts
*Delayed - data as of May 23, 2019  -  Find a broker to begin trading LH now
Exchange:NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
178.5
Today's High / Low
$ 166.65 / $ 164.25
Share Volume
748,864
90 Day Avg. Daily Volume
822,764
Previous Close
$ 167.46
52 Week High / Low
$ 190.355 / $ 119.38
Market Cap
16,374,640,000
P/E Ratio
18.91
Forward P/E (1y)
14.86
Earnings Per Share (EPS)
$ 8.79
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.9

Intraday Chart

Shares Traded

Share Volume:
748,864
90 Day Avg. Daily Volume:
822,764

P/E Ratio

P/E Ratio:
18.91
Forward P/E (1y):
14.86
Earnings Per Share (EPS):
$ 8.79

Trading Range

The current last sale of $166.24 is 39.25% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 166.65 $ 190.355
 Low: $ 164.25 $ 119.38

ETFs with LH as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
2.63% SPDR S&P Health Care Services ETF (XHS) +2.82 (4.53%)
1.82% Invesco S&P 500 Equal Weight Health Care ETF (RYH) +17.91 (10.21%)
1.11% Invesco Defensive Equity ETF (DEF) +7.08 (16.15%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Laboratory Corporation of America┬« Holdings (LabCorp┬« or the Company) is a leading global life sciences company that is deeply integrated in guiding patient care. The Company provides comprehensive clinical laboratory and end-to-end drug development services through LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). LabCorp is positioned at the convergence of research and care delivery to enable more precise and individualized healthcare, bringing together world-class diagnostics and drug development capabilities. With nearly 61,000 employees worldwide, the Company's mission is to improve health and improve lives by delivering world-class diagnostics, accelerating the availability of innovative medicines to patients, and using technology to change the way care is delivered. LabCorp, an S&P 500 company, was named to FORTUNE magazine's 2019 List of World's Most Admired Companies, making the annual list for the second consecutive year.  ... More ...  



Risk Grade

Where does LH fit in the risk graph?


Risk Grade Scale



Consensus Recommendation

Analyst Info